Replies to post #292112 on Amarin Corp Plc (AMRN)

[Bluensleepy]

Thank you sir.

[Biobillionair]

Thanks much appreciated! ~ 91,500/week... leaves millions of people at risk AMARIN MUST IMPROVE MESSAGE. Clearly we are damaged by Forbes “fish oil” campaign 2013 to 2019! I am unhappy with Amarin that they haven’t gone after Forbes. I see 63,000/week in damages, ~ $11.4 million in one week. I would seek punitive damages if this went to court. These 63,000 patients are at HUGE risk for a cardiovascular event.

BB

[Ray]

Thanks for the updated weekly script numbers. It appears the generics (primarily Teva) are still on our heals in the Marine market. I assume they have nothing in Reduce It. Is it possible to estimate our Reduce It scripts based on volume?

[invest2992]

Thank you for the Script numbers. What I don't understand is the amount of Nrx for Lovaza. Is it some doctors are just so misinformed, or is it pharmacists substituting Lovaza for Vascepa? And what about the doctors that still prescribe fibrates?

[Restingzebra]

Welcome back Tman. Missed you. Hope all is well. Thank you for the numbers. Good to see positive growth. Take care.

[moonotaur]

Encouraging numbers the last two weeks...begins to show what can happen with a media blitz. Let’s get this generic lawsuit victory then completely saturate the market with the Vascepa message.

[John603]

Welcome back and TY. Do the previous weeks look to have similar #'s?

[Hondo1021]

Thanks tucaman. ATH 2 consecutive weeks!!! Never apologize for taking a vacation. You surely earned it.

[tucaman]

Scripts for week ending 08/21/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 90'768 (-0.89%)
NRx: 42'301 (+0.32%)

Generic Lovaza
TRx: 62'917 (-0.13%)
NRx: 31'167 (+0.54%)